Researchers at Texas Medical Center’s Rice University recently discovered that Huntington’s Disease might be triggered by a repeating nucleotide sequence in the gene for a mutant protein. The research team conducted this study by analyzing proteins that were suspected to misfold and form plaques in the brains of patients with neurological diseases.
Read MoreTags: Texas Medical Center, Texas, Biotech Еvent, tmc, Biotechnology Vendor Fair, Southwest Region, Huntington's Disease
An estimated 30,000 people in the United States are afflicted with Huntington’s disease. Receiving a diagnosis of this genetic neurodegenerative disorder is unimaginably devastating. Sufferers slowly lose control of their movement and develop psychiatric problems over the course of 10-25 years, and often the disease is undetected until adulthood. Just this year, UC Davis researchers in Sacramento, California have discovered that human mesenchymal stem cells (MSCs) - cells with the ability to differentiate into bone cells, muscle cells, and other cell types - could be the key to developing an effective new therapy to treat Huntington’s. The promising findings are published in the journal Molecular Therapy.
Read MoreTags: Lab Product show, Stem cell research, Neuroscience, UC Davis - Medical Center, Huntington's Disease
Tags: Southern, FL, Florida, Tampa, BioResearch Product Faire Event, Huntington's Disease, 2016, University of South Florida, USF
Scientists at UC Irvine have created a new method to quickly and accurately track the progression of Huntington’s disease. Irvine researchers studied Huntington’s proteins present in spinal fluid to determine that they held a “seeding” property, which is essential to the disease’s progression.
Read MoreTags: CA, Bioresearch, University of California Irvine, California, 2015, disease research, Neuroscience, Research Funding, Neurology, Irvine, Southwest Region, UCI, UC Irvine, Huntington's Disease, BioResearch Product Faire™